5-218372-G-C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_004168.4(SDHA):​c.17G>C​(p.Gly6Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000766 in 1,304,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G6R) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 7.7e-7 ( 0 hom. )

Consequence

SDHA
NM_004168.4 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -2.08

Publications

6 publications found
Variant links:
Genes affected
SDHA (HGNC:10680): (succinate dehydrogenase complex flavoprotein subunit A) This gene encodes a major catalytic subunit of succinate-ubiquinone oxidoreductase, a complex of the mitochondrial respiratory chain. The complex is composed of four nuclear-encoded subunits and is localized in the mitochondrial inner membrane. Mutations in this gene have been associated with a form of mitochondrial respiratory chain deficiency known as Leigh Syndrome. A pseudogene has been identified on chromosome 3q29. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
CCDC127 (HGNC:30520): (coiled-coil domain containing 127) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03605482).
BP6
Variant 5-218372-G-C is Benign according to our data. Variant chr5-218372-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 862272.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SDHANM_004168.4 linkc.17G>C p.Gly6Ala missense_variant Exon 1 of 15 ENST00000264932.11 NP_004159.2
CCDC127NM_145265.3 linkc.-290C>G upstream_gene_variant ENST00000296824.4 NP_660308.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SDHAENST00000264932.11 linkc.17G>C p.Gly6Ala missense_variant Exon 1 of 15 1 NM_004168.4 ENSP00000264932.6
ENSG00000286001ENST00000651543.1 linkn.17G>C non_coding_transcript_exon_variant Exon 1 of 24 ENSP00000499215.1
CCDC127ENST00000296824.4 linkc.-290C>G upstream_gene_variant 1 NM_145265.3 ENSP00000296824.2

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
7.66e-7
AC:
1
AN:
1304750
Hom.:
0
Cov.:
31
AF XY:
0.00000155
AC XY:
1
AN XY:
644204
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26818
American (AMR)
AF:
0.00
AC:
0
AN:
24942
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20288
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31056
South Asian (SAS)
AF:
0.00
AC:
0
AN:
65358
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33764
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3668
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1045446
Other (OTH)
AF:
0.0000187
AC:
1
AN:
53410
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pheochromocytoma/paraganglioma syndrome 5;C5700310:Mitochondrial complex II deficiency, nuclear type 1 Uncertain:1
Jul 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 6 of the SDHA protein (p.Gly6Ala). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SDHA-related conditions. ClinVar contains an entry for this variant (Variation ID: 862272). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SDHA protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Hereditary cancer-predisposing syndrome Benign:1
Aug 19, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.10
DANN
Benign
0.52
DEOGEN2
Benign
0.23
T;T;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.69
T;T;T;T
M_CAP
Benign
0.076
D
MetaRNN
Benign
0.036
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.34
.;N;.;N
PhyloP100
-2.1
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
0.48
.;N;N;N
REVEL
Benign
0.061
Sift
Benign
1.0
.;T;T;T
Sift4G
Benign
0.75
T;T;T;T
Polyphen
0.0
.;B;B;.
Vest4
0.10
MutPred
0.33
Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);
MVP
0.076
MPC
0.52
ClinPred
0.057
T
GERP RS
-1.9
PromoterAI
-0.048
Neutral
Varity_R
0.023
gMVP
0.57
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs187964306; hg19: chr5-218487; API